期刊文献+

血浆标志物与ST段抬高型急性心肌梗死患者住院期间主要不良心脏事件相关性研究 被引量:11

Association of plasma biomarkers with major adverse cardiac events in patients with ST-segment elevation acute myocardial infarction
下载PDF
导出
摘要 目的检测ST段抬高型急性心肌梗死(STEAMI)患者血浆心肌肌钙蛋白I(cTnI)、精氨酸-加压素(AVP)、和肽素(COP)、心钠肽(ANP)、脑钠肽(BNP)、氨基末端脑钠肽原(NT-proBNP)和肾上腺素髓质素(ADM)浓度,探讨其对心肌梗死患者住院期间主要不良心脏事件(MACE)发生的预测价值。方法收集STEAMI患者和健康体检者各118例,ELISA法检测血浆cTnI、AVP、COP、ANP、BNP、NT-proBNP和ADM浓度,评价和比较其对急性心肌梗死患者住院期间主要MACE发生的预测价值。结果STEAM患者血浆cTnI、AVP、COP、ANP、BNP、NT-proBNP和ADM浓度均显著高于健康体检者(均P<0.01)。35例(29.7%)出现MACE。MACE患者血浆中上述激素的浓度均显著高于无MACE患者(均P<0.01)。ROC曲线分析显示,血浆中这些激素水平均可显著预测住院期间MACE发生(均P<0.01),而COP及NT-proBNP的预测价值优于cTnI(均P<0.05)。联合检测血浆COP及NT-proBNP可进一步提高血浆COP及NT-proBNP单独检测的预测价值(均P<0.05)。结论血浆COP及NT-proBNP浓度对STEAMI患者住院期间主要不良心脏事件的预测价值较高,而联合检测血浆COP及NT-proBNP浓度更具有临床价值。 Objective To investigate the association of plasma biomarkers with major adverse cardiac events(MACE) in patients with ST-segment elevation acute myocardial infarction(STEAMI). Methods One hundred and eighteen consecutive patients with STEAMI and 118 healthy subjects were enrolled in this study. Plasma cardiac troponin I (cTn I ), arginine vaso- pressin(AVP), copeptin, atrial natriuretic peptide(ANP), brain natriuretic peptide (BNP), N-terminal fragment of pro-brain natri- uretic peptide (NT-proBNP) and adrenomedullin (ADM) levels were measured by ELISA, and their association with in-hospital MACEs of patients was analyzed, Results Plasma cTn I, AVP, copeptin, ANP,BNP, NT-proBNP and ADM levels in STEAMI pa- tients were significantly higher than those in healthy controls (all P〈0.01). MACEs developed in 35 patients(29,7%) during hospi- talization. The plasma levels of these parameters in patients with MACEs were significantly elevated compared with patients with- out MACE (aft P〈0.01). ROC curve analysis showed that the predictive value of plasma copeptin and NT-proBNP for MACEs markedly exceeded that of plasma cTn I levels (both P〈0.05), and the combined determination of plasma copeptin and NT-proBNP further improved the predictive value of (both P〈0.05). Conclusion Plasma copeptin and NT-proBNP levels show high predictive values for occurrences of in-hospital MACEs in STEAMI patients and the combined determination of two biomarkers may further improve their predictive value.
出处 《浙江医学》 CAS 2015年第15期1299-1302,共4页 Zhejiang Medical Journal
基金 杭州市医药卫生科技计划项目(2012B051) 浙江省医药卫生科技计划项目(2013KYA176)
关键词 标志物 急性心肌梗死 预后 Biomarkers Acute myocardial infarction Prognosis
  • 相关文献

参考文献2

二级参考文献64

  • 1Steg PC., James SK, Atar D, et al.ESU Gmuennes for the management of acute myocardial infarction in pa- tients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J, 2012, 33 (20): 2569-2619.
  • 2Coviello I, Pinnacchio G, Laurito M, et al. Prognostic role of heart rate variability in patients with ST-segment elevation acute myocardial infarction treated by primary angioplasty. Cardiology, 2013, 124 (1): 63-70.
  • 3Kosuge M, Kimura K. Clinical implications of electrocardiograms for patients with anterior wall ST-segment elevation acute myocardial infarction in the interventional era. Circ J, 2012, 76 (1): 32-40.
  • 4Jochberger S, Morgenthaler NG, Mayr VD, et al. Copeptin and arginine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab, 2006, 91 (11): 4381-4386.
  • 5Mastropietro CW, Mahan M, Valentine KM, et al. C- opeptin as a marker of relative arginine vasopressin deficiency after pediatric cardiac surgery. Intensive Care Med, 2012, 38 (12): 2047-2054.
  • 6Yi SS, Kim H J, Do SG, et al. Arginine vasopressin (AVP) expressional changes in the hypothalamic paraventricular and supraoptic nuclei of stroke-prone spontaneously hypertensive rats. Anat Cell Biol, 2012, 45 (2): 114-120.
  • 7Liebetrau C, Nef H, Szardien S, et al. Release kinetics of eopeptin in patients undergoing transcoronary ablation of septal hypertrophy. Clin Chem, 2013, 59 (3): 566-569.
  • 8Boertien WE, Meijer E, Li J, et al. Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort. Am J Kidney Dis, 2013, 61 (3): 420-429.
  • 9Keller T, Tzikas S, Zeller T, et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coil Cardiol, 2010, 55 (19): 2096-2106.
  • 10Reichlin T, Hochholzer W, Stelzig C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol, 2009, 54 (1): 60-68.

共引文献12

同被引文献95

引证文献11

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部